Thyroid tablets, Levothyroxine and Liothyronine, recalled over ingredient concerns

Wednesday, August 15, 2018
A drug manufacturer has voluntarily recalled a thyroid medication, according to the U.S. Food and Drug Administration.

Stay on top of breaking news stories with the ABC11 News App
[Ads /]
Westminster Pharmaceuticals, LLC, is recalling Levothyroxine and Liothyronine medications in 15 mcg, 30 mcg, 60 mcg, 90 mcg and 120 mcg doses. They are all packed in 100-count bottles.

The medications contain an ingredient in them that was sourced prior to a 2017 FDA inspection that found deficiencies with the ingredient manufacturer's practices.

FIND OUT MORE: FDA information about the recall

The pharmaceutical company urges patients to ask their doctors about the next steps they should take before discontinuing the use of the medication.
[Ads /]
So far, it has not received any reports of adverse effects related to the product.



These tablets are used to treat patients with hypothyroidism.

Correction: A previous version of this article stated that two medications - Levothyroxine and Liothyronine - were recalled. According to the FDA, the recall is for the specific tablet that combines the two.
Copyright © 2024 KABC Television, LLC. All rights reserved.